ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Blood and Marrow Transplant Clinical Research Network

This study has been completed.

Sponsors and Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Blood and Marrow Transplant Clinical Trials Network
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00023530
  Purpose

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.


Condition Intervention
Bone Marrow Transplantation
Blood Disease
Hematopoietic Stem Cell Transplantation
Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
Graft vs Host Disease
Drug: fluconazole
Drug: voriconazole
Procedure: bone marrow transplant
Drug: thalidomide
Drug: dexamethasone

Genetics Home Reference related topics:   aceruloplasminemia    hemophilia   

MedlinePlus related topics:   Bone Marrow Transplantation    Cancer    Leukemia, Adult Acute    Leukemia, Adult Chronic    Leukemia, Childhood    Multiple Myeloma   

ChemIDplus related topics:   Dexamethasone    Dexamethasone acetate    Dexamethasone Sodium Phosphate    Doxiproct plus    Thalidomide    Fluconazole    Voriconazole   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Double-Blind, Placebo Control
Official Title:   Blood and Marrow Transplant Clinical Research Network

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:   September 2001
Study Completion Date:   August 2006

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Criteria for entry into a study varies by protocol

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00023530

Locations
United States, California
University of California at San Diego    
      La Jolla, California, United States, 92093
City of Hope National Medical Center    
      Duarte, California, United States, 91010
Stanford University    
      Palo Alto, California, United States, 94305
United States, Florida
University of Florida    
      Gainesville, Florida, United States, 32610
United States, Maryland
Johns Hopkins University    
      Baltimore, Maryland, United States, 21231
United States, Massachusetts
Dana-Farber Cancer Institute    
      Boston, Massachusetts, United States, 02115
United States, Michigan
University of Michigan at Ann Arbor    
      Ann Arbor, Michigan, United States, 48109
United States, Minnesota
University of Minnesota Twin Cities    
      Minneapolis, Minnesota, United States, 55455
United States, Missouri
Children's Mercy Hospital    
      Kansas City, Missouri, United States, 64108
United States, Nebraska
University of Nebraska Medical Center    
      Omaha, Nebraska, United States, 68198
United States, New York
Sloan-Kettering Institute for Cancer Research    
      New York, New York, United States, 10021
United States, North Carolina
Duke University    
      Durham, North Carolina, United States, 27705
United States, Ohio
Case Western Reserve University    
      Cleveland, Ohio, United States, 44106
United States, Pennsylvania
University of Pennsylvania    
      Philadelphia, Pennsylvania, United States, 19104
United States, Texas
MD Anderson Cancer Center    
      Houston, Texas, United States, 77030
United States, Washington
Fred Hutchinson Cancer Research Center    
      Seattle, Washington, United States, 98109

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Blood and Marrow Transplant Clinical Trials Network

Investigators
Investigator:     Joseph Antin     Dana-Farber Cancer Institute    
Investigator:     Frederick Appelbaum     Fred Hutchinson Cancer Research Center    
Investigator:     Edward Ball     University of California, San Diego    
Investigator:     James Ferrara     University of Michigan at Ann Arbor    
Investigator:     Stephen Forman     City of Hope National Medical Center    
Investigator:     Alan Gamis     Children's Mercy Hospital    
Investigator:     Sergio Giralt     M.D. Anderson Cancer Center    
Investigator:     Mary Horowitz     Medical College of Wisconsin    
Investigator:     Richard Jones     Johns Hopkins University    
Investigator:     Joanne Kurtzberg     Duke University    
Investigator:     Gina Laport     Stanford University    
Investigator:     Hillard Lazarus     Case Western Reserve University    
Investigator:     Richard O'Reilly     Sloan-Kettering Institute for Cancer Research    
Investigator:     Edward Stadtmauer     University of Pennsylvania    
Investigator:     Julie Vose     University of Nebraska    
Investigator:     Daniel Weisdorf     University of Minnesota    
Investigator:     John Wingard     University of Florida    
  More Information

Related Info  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   139
First Received:   September 7, 2001
Last Updated:   November 29, 2007
ClinicalTrials.gov Identifier:   NCT00023530
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Dexamethasone
Precancerous Conditions
Thalidomide
Clotrimazole
Graft versus host disease
Miconazole
Paraproteinemias
Hemostatic Disorders
Leukemia
Preleukemia
Hemorrhagic Disorders
Multiple myeloma
Voriconazole
Dexamethasone acetate
Myelodysplastic syndromes
Fluconazole
Immunoproliferative Disorders
Hematologic Diseases
Blood Coagulation Disorders
Myelodysplastic Syndromes
Myelodysplasia
Tioconazole
Vascular Diseases
Multiple Myeloma
Homologous wasting disease
Graft vs Host Disease
Lymphoproliferative Disorders
Bone Marrow Diseases
Neoplasms, Plasma Cell

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Anti-Infective Agents
Immunologic Factors
Blood Protein Disorders
Antineoplastic Agents
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Antiemetics
Hormones
Anti-Bacterial Agents
Pathologic Processes
Syndrome
Therapeutic Uses
Antifungal Agents
Cardiovascular Diseases
Growth Inhibitors
Angiogenesis Modulating Agents
Disease
Neoplasms by Histologic Type
Immune System Diseases
Antineoplastic Agents, Hormonal
Growth Substances
Gastrointestinal Agents
Angiogenesis Inhibitors
Glucocorticoids
Immunosuppressive Agents
Pharmacologic Actions
Neoplasms
Autonomic Agents
Peripheral Nervous System Agents

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers